TECARTUS
Live / Registered — Registered (as of 22 Dec 2020)
What this means for you
Registered since 22 Dec 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 22 Dec 2026, and its filing window is open now).
Record
- Serial number
- 88560305
- Registration number
- 6229181
- Mark type
- Word mark
- Filed
- 01 Aug 2019
- Published for opposition
- 15 Oct 2019
- Registered
- 22 Dec 2020
- Next maintenance filing
- §8 declaration of use, due by 22 Dec 2026 (grace period to 22 Jun 2027)
- Attorney of record
- Cynthia Smuzynska
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of cancer; pharmaceutical and biological preparations for immunotherapy, including for T-Cell immunotherapy
Owner
- Kite Pharma, Inc., Santa Monica, CA, US
- Kite Pharma, Inc., Santa Monica, CA, US
- Kite Pharma, Inc., Santa Monica, CA, US
Prosecution history
- 09 Jul 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Jul 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Jul 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Jul 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Jul 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Dec 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 18 Nov 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Nov 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Nov 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Oct 2020 — USE AMENDMENT FILED
- 10 Nov 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Oct 2020 — TEAS STATEMENT OF USE RECEIVED
- 22 Oct 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Oct 2020 — SOU EXTENSION 2 GRANTED